James O. Kahn - Concepedia

Author

James O. Kahn

San Francisco General Hospital

Also Known As

Delaney, Joseph A.C., J Kahn, J O Kahn, J. O. Kahn, J.O. Kahn, James Kahn, James O Kahn, James O. Kahn, James O. Kahn

Publications

7.6K

Citations

H-Index

Concepts

All Affiliations

San Francisco General Hospital University of California, San Francisco San Francisco AIDS Foundation Harvard University Massachusetts General Hospital

About

James O. Kahn is an author at San Francisco General Hospital specializing in medicine, hiv, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	18	1.7K
2	Epidemiology	5	5	505
3	Public Health	2	2	95
4	Cell Biology	2	2	41
5	Allergy	1	1	37

James O. Kahn

Publications

6.7K

Citations

H-Index

Page 1

	Year	Citations
Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load Steven G. Deeks, Christina M. Ramirez, Hua Guo, Blood	2004	784
Sexual Transmission of an HIV-1 Variant Resistant to Multiple Reverse-Transcriptase and Protease Inhibitors Frederick Hecht, Robert M. Grant, Christos J. Petropoulos, New England Journal of Medicine Protease InhibitorsSexual HealthHuman RetrovirusImmunologyReverse Transcriptase	1998	452
Cellular Immune Responses and Viral Diversity in Individuals Treated during Acute and Early HIV-1 Infection Marcus Altfeld, Eric Rosenberg, Raj Shankarappa, The Journal of Experimental Medicine Early Hiv-1 InfectionAcute Hiv InfectionImmunologyCd4 T Cell ResponsesImmune System	2001	384
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection Marcus Altfeld, Marylyn M. Addo, Eric Rosenberg, AIDS	2003	355
A Controlled Trial Comparing Continued Zidovudine with Didanosine in Human Immunodeficiency Virus Infection James O. Kahn, Stephen W. Lagakos, Douglas D. Richman, New England Journal of Medicine	1992	347
Phase I/II Trial of the Pharmacokinetics, Safety, and Antiretroviral Activity of Tenofovir Disoproxil Fumarate in Human Immunodeficiency Virus-Infected Adults Patricia Barditch‐Crovo, Steven G. Deeks, Ann Collier, Antimicrobial Agents and Chemotherapy	2001	332
Use of laboratory tests and clinical symptoms for identification of primary HIV infection Frederick Hecht, Michael P. Busch, B. D. Rawal, AIDS	2002	294
Predicting the unpredictable: Transmission of drug-resistant HIV Sally Blower, A.N. Aschenbach, Hayley B. Gershengorn, Nature Medicine Sexual HealthInfectious Disease ModellingPredictive AnalyticsViral DynamicResistance Mutation (Virology)	2001	223
Efficacy and Safety of Adefovir Dipivoxil With Antiretroviral Therapy<SUBTITLE>A Randomized Controlled Trial</SUBTITLE> James O. Kahn JAMA	1999	202
Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma: results of a randomized trial. Lawrence D. Kaplan, James O. Kahn, Suzanne M. Crowe, Journal of Clinical Oncology Primary ImmunodeficiencyLymphoid NeoplasiaGranulocyteMedicineHematology	1991	196

Page 1